C07D 411/04
Directly linked by a ring-member-to-ring-member bond
Official title: directly linked by a ring-member-to-ring-member bond
C07D411/04 (Directly linked by a ring-member-to-ring-member bond) appears on 212 US grants and 150 published applications in this corpus.
Search patents in C07D- Granted patents
- 212
- Published applications
- 150
- Assignees
- 114
- Inventors
- 537
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 9 | 0 |
| 1994 | 7 | 0 |
| 1995 | 9 | 0 |
| 1996 | 10 | 0 |
| 1997 | 11 | 0 |
| 1998 | 14 | 0 |
| 1999 | 9 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 1 |
| 2002 | 6 | 8 |
| 2003 | 6 | 9 |
| 2004 | 9 | 8 |
| 2005 | 4 | 9 |
| 2006 | 6 | 7 |
| 2007 | 3 | 5 |
| 2008 | 3 | 2 |
| 2009 | 4 | 7 |
| 2010 | 1 | 11 |
| 2011 | 2 | 10 |
| 2012 | 6 | 4 |
| 2013 | 6 | 8 |
| 2014 | 5 | 5 |
| 2015 | 8 | 8 |
| 2016 | 2 | 10 |
| 2017 | 10 | 6 |
| 2018 | 3 | 3 |
| 2019 | 3 | 5 |
| 2020 | 5 | 3 |
| 2021 | 0 | 6 |
| 2022 | 4 | 4 |
| 2023 | 3 | 2 |
| 2024 | 3 | 5 |
| 2025 | 2 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Organic electroluminescent compound and organic electroluminescent device including the same30 Sep 2025US 12,428,407 B2Sfc Co., Ltd.
- Compositions and methods for treating retinal degradation15 Apr 2025US 12,274,701 B2University of Kentucky Research Foundation
- Compositions and methods for treating retinal degradation24 Sep 2024US 12,097,201 B2University of Kentucky Research Foundation
- Electrolytic solution, and electrochemical device using the same17 Sep 2024US 12,095,035 B2Ningde Amperex Technology Limited
- Compositions and methods for treating multiple sclerosis4 Jun 2024US 11,998,547 B2University of Kentucky Research Foundation
- Therapeutic alkaloid compounds13 Aug 2026US 2026/0234131 A1Sensorium Therapeutics, Inc.
- Organic electroluminescent compound and organic electroluminescent device including the same25 Dec 2025US 2025/0388570 A1Sfc Co., Ltd.
- Electrolyte, secondary battery, and electric apparatus18 Dec 2025US 2025/0385321 A1Contemporary Amperex Technology Co., Limited
- Mk2 inhibitors and methods of making and using the same13 Feb 2025US 2025/0051309 A1Gilead Sciences, Inc.
- Compositions and methods for treating retinal degradation5 Dec 2024US 2024/0398803 A1University of Kentucky Research Foundation
Most cited
By later US patents
- 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties128US 5,047,407 AIAF BioChem International, Inc. · 1991
- Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds108US 5,210,085 AEmory University · 1993
- 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections104US 5,041,449 AIAF BioChem International, Inc. · 1991
- Method and compositions for the synthesis of BCH-189 and related compounds92US 5,204,466 AEmory University · 1993
- Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds91US 5,814,639 AEmory University · 1998